Thieme E-Books & E-Journals -
CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg 2022; 70(S 03): e15-e20
DOI: 10.1055/s-0042-1756493
Pediatric and Congenital Cardiology

Risk Assessment of Red Cell Transfusion in Congenital Heart Disease

Authors

  • Christoph Zürn

    1   Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • René Höhn

    1   Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • David Hübner

    2   Department of Machine Learning for Medical Applications, Averbis GmbH, Freiburg, Germany
  • Markus Umhau

    3   Institute for Transfusion Medicine and Gene Therapy, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • Johannes Kroll

    4   Department of Cardiovascular Surgery, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • Fabian A. Kari

    4   Department of Cardiovascular Surgery, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • Frank Humburger

    5   Department of Anesthesiology and Critical Care, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • Sven Maier

    4   Department of Cardiovascular Surgery, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
  • Brigitte Stiller

    1   Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany